The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.
Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004
Abstract
Detection of hypertension and blood pressure control are critically important for reducing the risk of heart attacks and strokes. We analyzed the trends in the prevalence, awareness, treatment, and control of hypertension in the United States in the period 1999–2004. We used the National Health and Nutrition Examination Survey 1999–2004 database. Blood pressure information on 14 653 individuals (4749 in 1999–2000, 5032 in 2001–2002, and 4872 in 2003–2004) aged ≥18 years was used. Hypertension was defined as blood pressure ≥140/90 mm Hg or taking antihypertensive medications. The prevalence of hypertension in 2003–2004 was 7.3±0.9%, 32.6±2.0%, and 66.3±1.8% in the 18 to 39, 40 to 59, and ≥60 age groups, respectively. The overall prevalence was 29.3%. When compared with 1999–2000, there were nonsignificant increases in the overall prevalence, awareness, and treatment rates of hypertension. The blood pressure control rate was 29.2±2.3% in 1999–2000 and 36.8±2.3% in 2003–2004. The age-adjusted increase in control rate was 8.1% (95% CI: 2.4 to 13.8%; P =0.006). The control rates increased significantly in both sexes, non-Hispanic blacks, and Mexican Americans. Among the ≥60 age group, the awareness, treatment, and control rates of hypertension had all increased significantly ( P ≤0.01). The improvement in blood pressure control is encouraging, although the prevalence of hypertension has not declined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Two lower quality studies [405, 406] and five well-done studies [407–411] (13%, including one at a trend level), however, reported higher BP in the more R/S or with religious fasting.”
From Religion, Spirituality, and Health: The Research and Clinical Implications (2012) · cites this paper as [405]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Prevalence of Overweight and Obesity in the United States
Crespo, C. J., & Smit, E. (2003) · Human Kinetics eBooks · doi:10.5040/9781718206601.ch-001 · Cited by 4,382
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Julius, S., Kjeldsen, S. E., Weber, M. A., Brunner, H. R., Ekman, S., Hansson, L., Hua, T. A., Laragh, J. H., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,557
Hajjar, I. M. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,399
Research works printed but not linked: 4
- Plan and operation of the Third National Health and Nutrition Examination Survey 1988–94. Vital Health Stat 1. 1994; 32: 1–407.
- 10.1161/circ.88.5.8222141 · DOI
- Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected US population. Healthy People 2010. Stat Notes. 2001; 20: 1–10.
- US Department of Health and Human Services. Healthy People 2010 (conference ed in 2 vols). Washington DC: US Department of Health and Human Services; 2000. Available at: http://www.health.gov/healthypeople. Accessed April 24 2006.
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Hubungan Kadar Kolesterol Total dengan Tekanan Darah pada Masyarakat Jatinangor
Ulfah, M., Sukandar, H., & Afiatin, A. (2017) · Jurnal Sistem Kesehatan · doi:10.24198/jsk.v3i2.15004 · Cited by 8
Prediction of the hypertension risk in teenagers
Wieniawski, P., & Werner, B. (2020) · Cardiology Journal · doi:10.5603/cj.a2020.0079 · Cited by 8
Sebastian, R. S., Kuczmarski, M. F., Enns, C. W., Goldman, J. D., Murayi, T., Moshfegh, A. J., Zonderman, A. B., & Evans, M. K. (2021) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2021.104124 · Cited by 8
Fatima, I., Ihsan, H., Masoud, M. S., Kalsoom, S., Aslam, S., Rehman, A., Ashfaq, U. A., & Qasim, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269739 · Cited by 9
“Often, HTN is asymptomatic and people don’t visit any doctor which leads to complications [10].”
BackgroundRetractedLevy, P. D., Twiner, M. J., Brody, A., Dawood, R., Reed, B. P., Mango, L., Gowland, L., Grandits, G., Svendsen, K. H., Haacke, E. M., et al. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac096 · Cited by 8
Relationship between birth head circumference and adulthood quality of life in Chinese people
Xu, T., Zhang, Z., Han, S., Hu, H., Xiao, X., Gong, X.-M., Chen, X., Wang, Z., & Liu, A. (2010) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2010.01819.x · Cited by 8
Analysis for hypertension and related risk factors of physical examination population.
Qiao, S., Ye, Q., Dou, Y., Li, M., Kou, Y., Qian, D., Li, M., & Wang, G. (2013) · Europe PMC (PubMed Central) · Cited by 8
Wong, K. S., Smalarz, A. M., Wu, N., Boulanger, L., & Wogen, J. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.08.002 · Cited by 8
Efficacy and safety of olmesartan medoxomil alone and in combination with hydrochlorothiazide
Punzi, H. A. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.7.3.229 · Cited by 8
Now or Never: Optimal Antihypertensive Therapy in the Elderly
Prisant, L. M. (2008) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.00005.x · Cited by 8
Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension
Kjeldsen, S. E., Schmieder, R. E., Unger, T., & Mancia, G. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003635178 · Cited by 8
Zappe, D. H., Palmer, B. F., Calhoun, D. A., Purkayastha, D. S., Samuel, R., & Jamerson, K. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.90 · Cited by 8
Review: A Single-Pill Combination of Telmisartan plus Amlodipine for the Treatment of Hypertension
Guthrie, R. M. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.11.2495 · Cited by 8
How to avoid discontinuation of antihypertensive treatment. The experience in São Paulo, Brazil
Ortega, K. C., de Gusmão, J. L., Pierin, Â. M. G., Nishiura, J. L., Ignez, E. C., Segre, C. A. W., Ventura, C. G., Mano, G. M. P., Fontes, V., da Cunha, F. M., et al. (2010) · Clinics · doi:10.1590/s1807-59322010000900008 · Cited by 8
“pathy (1), diabetic decompensation (1), syncope (1), nephrectomy (2), trauma (2), peritoneal bypass (1), diarrhea (1) and gastrectomy (1).”
BackgroundPrevalence and risk factors for hypertension among Bulawayo City Council employees, 2010
Marwiro, A. (2012) · University of Zimbabwe Institutional Repository (University of Zimbabwe) · Cited by 8
Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988–1994 to 2001–2006
King, D. E., Ellis, T. M., Everett, C. J., & Mainous, A. G. (2009) · Southern Medical Journal · doi:10.1097/smj.0b013e3181bc74c8 · Cited by 8
A Novel UV-Spectrophotometric Method for Simultaneous Estimation of Amlodipine and Captopril
Murtaza, G., Akhtar, Y., Mahmood, T., Abid, S. M. A., & Makreski, P. (2019) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-019-01932-1 · Cited by 8
Fishman, B., Leiba, A., Twig, G., Shlomai, G., Orr, O., Landau, R., Derazne, E., & Grossman, E. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz167 · Cited by 8
Credibility of self-reported health parameters in elderly population
Amster, R., Reychav, I., McHaney, R., Zhu, L., & Azuri, J. (2020) · Primary Health Care Research & Development · doi:10.1017/s1463423620000201 · Cited by 8
“Hypertension prevalence rises in the older population, resulting in higher levels of treatment within this group (Ong et al., 2007).”
BackgroundPrevalence, awareness, treatment and control of hypertension in a rural Nicaraguan sample
Blondin, N., & Lewis, J. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002225 · Cited by 8
Creatine Kinase and the Correlates of Blood Pressure in a Random Population Sample
Brewster, L. M., Stronks, K., Zwinderman, A. H., & van Montfrans, G. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091835 · Cited by 8
Beware of Unawareness: Racial/Ethnic Disparities in Awareness of Chronic Diseases
Chatterji, P., Joo, H., & Lahiri, K. (2010) · National Bureau of Economic Research · doi:10.3386/w16578 · Cited by 8
Learning health system linchpins: information exchange and a common data model
Eisman, A. S., Chen, E. S., Wu, W., Crowley, K. M., Aluthge, D. P., Brown, K., & Sarkar, I. N. (2024) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocae277 · Cited by 6
Wu, Y.-K., Hu, G.-P., Pan, F.-J., Liu, J.-H., Mo, X.-Y., Xie, Y.-P., Liang, D.-H., Lei, Z.-J., & Liang, B.-F. (2016) · Clinical and experimental hypertension · doi:10.3109/10641963.2016.1151525 · Cited by 8
Butzner, M., Oyekanmi, C. O., McDuffie, M. J., Nescott, E., McCullers, A., Woldeamanuel, E., Lynn, E., & Cuffee, Y. (2023) · Population Health Management · doi:10.1089/pop.2022.0270 · Cited by 7
Ullah, S., Khan, S., Bazargan‐Hejazi, S., Ramirez, E. R., Teklehaimanot, S., Diab, S., Bangash, M., & Shaheen, M. A. (2023) · Health Promotion Perspectives · doi:10.34172/hpp.2023.17 · Cited by 7
Why Physicians Do Not Prescribe a Thiazide Diuretic
Sutton, E., Wilson, H., Kaboli, P. J., & Carter, B. L. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00299.x · Cited by 7
Interactions Between Obesity, Parental History of Hypertension, and Age on Prevalent Hypertension
Katz, E. G., Stevens, J., Truesdale, K. P., Cai, J., & North, K. E. (2011) · Asia Pacific Journal of Public Health · doi:10.1177/1010539511409393 · Cited by 7
“In young adults (24-39 years), the prevalence of hypertension/1000 persons (95% confidence interval [CI]) at the referent BMI was greater among subjects with a parental history of hypertension (35; 15-54) compared with those without (7; 3-11).”
BackgroundClapauch, R., Mecenas, A. S., Maranhao, P. A., & Bouskela, E. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31823a8f43 · Cited by 7
Yoo, J., Okada, Y., Best, S. A., Parker, R. S., Hieda, M., Levine, B. D., & Fu, Q. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001046 · Cited by 7
Nunes, A., Alves, P. H., Mendes, E. P., Ianzer, D. A., & Castro, C. H. (2018) · Peptides · doi:10.1016/j.peptides.2018.10.005 · Cited by 7
Lung, Y.-J., Weng, W., Wu, C.-L., & Huang, W. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.12.030 · Cited by 7
Akonobi, A., & Khan, J. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.19204/2019/syst4 · Cited by 7
Sharp, G., & Carpiano, R. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282648 · Cited by 7
Ghofrani, H. A., Weaver, F. A., & Nadim, M. K. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.09.003 · Cited by 7
Germino, F. W., Neutel, J. M., Dubiel, R., Maa, J., & Chavanu, K. J. (2012) · American Journal of Cardiovascular Drugs · doi:10.1007/bf03261841 · Cited by 7
Differential Genetic Basis for Pre-Menopausal and Post-Menopausal Salt-Sensitive Hypertension
Herrera, V. L. M., Pasion, K. A., Moran, A. M., & Ruiz‐Opazo, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043160 · Cited by 7
“Moreover, essential hypertension affects a substantial proportion of post-menopausal women in United States approaching 75% of this population [8] with an increased prevalence of salt-sensitive hypertension [9–11].”
BackgroundFixed-dose combination and chronic kidney disease progression: which is the best?
Hopkins, K. A., & Bakris, G. L. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32833b9771 · Cited by 7
Oigman, W., Gomes, M. A. M., Pereira-Barretto, A. C., Póvoa, R., Kohlmann, O., Rocha, J. C., & Nobre, F. D. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.03.015 · Cited by 7
Qvist, I., Thomsen, M. D., Lindholt, J. S., Ibsen, H., Hendriks, J., & Frost, L. (2014) · Clinical Epidemiology · doi:10.2147/clep.s53706 · Cited by 7
Implications of recent clinical trials on pay-for-performance
Gellad, W. F., Detsky, A. S., & Choudhry, N. K. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080577 · Cited by 7
“For example, only 37% of people with hypertension have their blood pressure controlled and only 65% of hypertensive patients are being treated.(9) Therefore, creating incentives to better control chronic diseases makes conceptual sense.”
BackgroundBlood Pressure Control and Predictors of Uncontrolled Hypertension
Bannay, R. A., Husain, A., & Böhm, M. (2014) · Bahrain Medical Bulletin · doi:10.12816/0008110 · Cited by 7
Susa, N., Nishida, Y., Yada, Y., Nakayama, T., Asai, S., & Takahashi, Y. (2015) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2015.1081214 · Cited by 7
Isfeedvajani, M. S., Zarchi, A. A. K., Heris, A. M., Sajjadi, F., & Tavana, A. M. (2014) · Europe PMC (PubMed Central) · Cited by 7
Baran, A. K., Demirci, H., Budak, E., Candar, A., & Akpınar, Y. (2017) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2017.07.004 · Cited by 7
Yang, S., Chen, Y., Liu, C., Zhao, X., Zhuang, Q., Sun, J., Wei, P., Zhao, H., Chen, X., & Shen, C. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx089 · Cited by 8
Barrios, V., & Escobar (2010) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s6636 · Cited by 7
Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension
Niemeijer, M. G., & Cleophas, T. J. (2009) · Pharmaceuticals · doi:10.3390/ph2030125 · Cited by 7
“0%) (throughout the article 95% confidence intervals of point estimates are given) and is increasing [1].”
BackgroundCompetence of Polish primary‐care doctors in the pharmacological treatment of hypertension
Windak, A., Gryglewska, B., Tomasik, T., Narkiewicz, K., Yaphe, J., & Grodzicki, T. K. (2010) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.01107.x · Cited by 7
Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 study
Kobalava, Z. D., Kotovskaya, Y. V., Вадимовна, В. С., Моисеев, В. С., & study, O. B. O. T. R. O. T. R. A.-2. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903157531 · Cited by 7
MacDonald, K., Lee, C. S., Chen, H. C., Ko, M. L., Fidel, G. E., Brié, H., Hermans, C., Vancayzeele, S., Reel, S., der Niepen, P. V., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.71 · Cited by 7
Margozzini, P., Rigotti, A., Catterina Ferreccio, R., Quezada, N., Garrido, M. N. D., & Valdés, G. (2007) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944707082716 · Cited by 7
“The lack of differences in the attainment of normotension observed at the different 88 http://tac.sagepub.com educational levels in ENS indicates that this goal may not be as responsive to economic resources in low income countries as in higher income societies [Ong et al. 2007].”
BackgroundResultWang, L., & Wang, K. (2013) · Psychiatry Journal · doi:10.1155/2013/979623 · Cited by 9
“These difficulties may become more obvious by lower awareness among young and middleaged adults of their heart disease risk and reluctance on the treatment of CVD risk factors at younger ages [53, 54].”
BackgroundUnmet Needs in Managing Hypertension: Potential Role of Direct Renin Inhibition
Ruddy, M. C. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.05.2159 · Cited by 7
Hypertension Control: Improved, but not enough!
ALDERMAN, M. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.02.002 · Cited by 7
“Recognition of these possibilities, coupled with sensitivity to patient needs and preferences, will not solve the whole problem, but is likely to help”
BackgroundLi, J., Jiang, C., Ma, J., Bai, F., Yang, X., Zou, Q., & Chang, P. (2025) · Medicine · doi:10.1097/md.0000000000041608 · Cited by 6
Elevations in serum creatinine with RAAS blockade: why isnʼt it a sign of kidney injury?
Ryan, M. J., & Tuttle, K. R. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e32831daeff · Cited by 6
Obesity and Hypertension: A Common Coexistence
Mende, C. W. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00578.x · Cited by 6
Self-Care in Patients With Hypertension in Indonesia
Eldawati, E., Said, F. M., & Umar, N. S. (2022) · KnE Life Sciences · doi:10.18502/kls.v7i2.10347 · Cited by 7
Gaglioti, A. H., Rivers, D. A., Ringel, J. B., Judd, S. E., & Safford, M. M. (2022) · Preventing Chronic Disease · doi:10.5888/pcd19.210195 · Cited by 6
High-Risk Patients with Hypertension: Clinical Management Options
McNaughton, C. D., Self, W. H., Levy, P. D., & Barrett, T. W. (2012) · Clinical Medicine Reviews in Vascular Health · doi:10.4137/cmrvh.s8109 · Cited by 6
ARTERIAL HYPERTENSION PREVALENCE IN MOSCOW IN DIFFERENT TIME INTERVALS
Balanova, Y. А., Shalnova, S. A., Деев, А. Д., Vv, K., & Владимировна, К. А. (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-2-102-108 · Cited by 6
Control of Blood Pressure in North Carolina Primary Care: Baseline Data from the GLAD Heart Trial
Rosenberger, E. L., Goff, D. C., Davis, C., Blackwell, C. S., & Bertoni, A. G. (2008) · North Carolina Medical Journal · doi:10.18043/ncm.69.6.441 · Cited by 6
Derosa, G., Cicero, A. F. G., Carbone, A., Querci, F., Fogari, E., D’Angelo, A., & Maffioli, P. (2012) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12021 · Cited by 6
RetractedBASILE, J. N. (2010) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s9691 · Cited by 6
Suárez, C., Galgo, A., Mantilla, T., Leal, M., & Escobar, C. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313483609 · Cited by 6
“It is estimated that approximately 30% of the general population has hypertension, and the proportion increases to twothirds in older individuals.(1,2) The control of blood pressure (BP) is crucial in the prevention of cardiovascular outcomes, including myocardial infarction, stroke, heart failure, and renal failure.”
BackgroundCorsino, L., Yancy, W. S., Samsa, G. P., Dolor, R. J., Pollak, K. I., Lin, P., & Svetkey, L. P. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00385.x · Cited by 6
Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension
Chrysant, S. G. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.85 · Cited by 6
Impact of Literacy on the Prevalence, Awareness, Treatment andControl of Hypertension in Iran
Veghari, G., Sedaghat, M., Maghsodlo, S., Banihashem, S., Moharloei, P., Angizeh, A., Tazik, E., & Moghaddami, A. (2012) · Europe PMC (PubMed Central) · doi:10.5681/jcvtr.2012.009 · Cited by 6
Greene, R. S., Quinones, M. E., & Edwards, K. L. (2007) · Pharmacy Practice · doi:10.4321/s1886-36552007000300006 · Cited by 6
Wong, M. C. S., Wang, H., Jiang, J. Y., Leeder, S., & Griffiths, S. M. (2011) · Asia Pacific Family Medicine · doi:10.1186/1447-056x-10-10 · Cited by 6
Toufan, M., Azarfarin, R., Sadati, B., & Golzari, S. E. (2012) · Europe PMC (PubMed Central) · doi:10.5681/jcvtr.2012.008 · Cited by 6
Schweizer, J., Ulmer, H.-J., Benduhn, H., & Klebs, S. H. G. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.537318 · Cited by 6
Renin-Angiotensin Aldosterone System and Hypertension: Current Approaches and Future Directions
Flack, J. M., Atlas, S. A., Pool, J. L., & White, W. B. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.s8-b.1 · Cited by 6
Posnenkova, O. M., Kiselev, A. R., Gridnev, V. I., Shvartz, V. A., Dovgalevsky, P. Y., & Oschepkova, E. V. (2011) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2011-7-6-725-732 · Cited by 6
Genetic polymorphisms and related risk factors of ischemic stroke in a Mongolian population in China
Wu, Q., Wu, H., Orlov, Y. L., Gegentana, G., Huo, W., Брагин, А. О., Wu, N., Suyalatu, S., Zhao, F., Zhao, J., et al. (2017) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj17.275 · Cited by 6
Huang, W., Weng, W., Su, F.-C., & Lin, S.-W. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.07.042 · Cited by 6
Westcott, W. L. (2015) · ACSMʼs Health & Fitness Journal · doi:10.1249/fit.0000000000000134 · Cited by 6
L-arginase induces vascular dysfunction in old spontaneously hypertensive rats.
Arishe, O. O., McKenzie, J., Priviero, F. B. M., Ebeigbe, A. B., & Webb, R. C. (2019) · Journal of African Association of Physiological Sciences · Cited by 6
Possibility of Using Fermented Curly Kale Juice to Manufacture Feta-Type Cheese
Michalak-Tomczyk, M., Skrzypczak, K., Nastaj, M., Terpiłowski, K., Skrzypek, T., Waśko, A. D., & Polak‐Berecka, M. (2020) · Applied Sciences · doi:10.3390/app10114020 · Cited by 6
“[52] suggested that the small molecular mass products (short peptides and amino acids) come from the activity of bacterial proteases towards products in a range from 28 to 18 kDa (casein fractions and β-lactoglobulin, respectively).”
BackgroundCordova-Marks, F. M., Zibadi, S., & WATSON, R. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397156-2.00255-6 · Cited by 6
Quality Improvement Initiative for Rapid Induction of Hypertension Control in Primary Care
Naik, A. D., Rodriguez, E. M., Rao, R., Teinert, D., Abraham, N. S., & Kalavar, J. S. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.913137 · Cited by 6
Physical activity reduced hypertension in the elderly and cost-effective
Gandasentana, R. D., & Kusumaratna, R. K. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.18051/univmed.2011.v30.173-181 · Cited by 6
Devyatkin, V. A., Redina, O. E., Muraleva, N. A., & Kolosova, N. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103542 · Cited by 6
Abraham, I. L., Demosthenes, L., MacDonald, K., Lee, C. S., Reel, S., Brié, H., Hermans, C., Vancayzeele, S., & der Niepen, P. V. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2009.07.009 · Cited by 6
“, 2008) and even more so in patients age 60 and older (Gasse et al.; 2001; Hajjar and Kotchen, 2003; Primatesta and Poulter, 2004; Lloyd-Jones et al., 2005; Ong et al., 2007; Ostchega et al., 2007).”
BackgroundHypertensive Treatment in Patients With Metabolic Syndrome
Siegel, D., & Swislocki, A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0086 · Cited by 6
Optimizing Management of Hypertension With Combination Therapy
Roberts, M. E., & Epstein, B. J. (2009) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181aed18e · Cited by 6
Early Implant Failure in Patients Using Antihypertensive Medications: A Retrospective Cohort Study
Masri, D., Bar-Hai, D., Masri‐Iraqi, H., Kahn, A., Chaushu, G., & Chaushu, L. (2024) · International Dental Journal · doi:10.1016/j.identj.2024.05.003 · Cited by 5
Daredia, S., Riddell, C. A., Khodasevich, D., Bozack, A. K., Harley, K. G., Kogut, K. R., Mora, A. M., Holland, N., Eskenazi, B., Deardorff, J., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.043818 · Cited by 6
Ertaş, F., Yavuz, C., Kaya, H., Karahan, O., Demirtaş, S., Acet, H., Oylumlu, M., Akıl, M. A., Bilik, M. Z., & Alan, S. (2013) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.764891 · Cited by 5
“Hypertension thus remains an important etiologic factor for many cardiovascular events (13).”
BackgroundAntihypertensive Therapy in African Americans: Findings From an Inner‐City Ambulatory Clinic
Odigie‐Okon, E., ZARICH, S. W., Okon, E., & Dufresne, A. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00248.x · Cited by 5
Long-Term Blood Pressure Control: What Can We Do?
Neutel, J. M. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.01.2249 · Cited by 5
Pharmacological Risk Assessment for Dental Implants
Wu, X., & Tamimi, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-71181-2_4 · Cited by 5
Lederer, S., Ruggiero, L., Sisen, N. M., LePain, N., O’Connor, K. G., Wang, Y., Chen, J., Lash, J. P., & Fischer, M. J. (2018) · BMC Nephrology · doi:10.1186/s12882-018-1079-y · Cited by 5
Wu, C.-I., Wu, C.-L., Su, F.-C., Lin, S.-W., & Huang, W. (2020) · European Neurology · doi:10.1159/000512407 · Cited by 5
Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory
Moura, A. F., Moura-Neto, J. A., Rodrigues, C. I. S., Miranda, M. O., Carvalho, T. C., Carvalho, N. P. P., Souza, E., Moura-Jr, J. A., & Cruz, C. M. S. (2021) · SAGE Open Medicine · doi:10.1177/20503121211020892 · Cited by 7
Lewis, J., Suchy‐Dicey, A. M., Noonan, C., Jernigan, V. B. B., Umans, J. G., Domoto‐Reilly, K., Buchwald, D., & Manson, S. M. (2021) · Journal of Aging and Health · doi:10.1177/08982643211013696 · Cited by 5
“…prevalence of covert VBI has been reported for the general population, even in people without a history of CBVD (Akins et al., 2013; Dickerson et al., 2012), and it has also been associated with increased risk of subsequent stroke and death (Go et al., 2013; Ong et al., 2007; Robin et al., 1998).”
BackgroundCao, X., Li, R., Tang, W., Wang, W., Ji, J., Yin, C., Niu, L., Gao, Y., & Ma, Q. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04656-4 · Cited by 5
“Although improvement in patient awareness and the treat-ment of hypertension and diabetes in China, the proportion of individuals whose hypertension and diabetes were controlled was less than 50%, which was lower than those in the developed countries [32, 33].”
ResultAT1 Receptors, Angiotensin Receptor Blockade, and Clinical Hypertensive Disease
Carey, R. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-186-8_6 · Cited by 5
“In the United States during 2003–2004, only 33% of hypertensive patients had controlled BP and only 64% of patients treated for hypertension achieved BP control [7].”
BackgroundReview of Cardiovascular Effects of ADHD Medications
Levin, C. J., Goodman, D. W., & Adler, L. A. (2018) · Psychiatric Annals · doi:10.3928/00485713-20180612-01 · Cited by 3
“18,19 The possibility of increased cardiovascular mortality secondary to medication use has led to a substantial body of research assessing the long-term cardiovascular outcomes in people treated for ADHD with medication.”
Metadata
- Authors
- Ong, K. L., Cheung, B. M. Y., Man, Y. B., Lau, C. P., & Lam, K. S. L.
- Affiliations
- University of Hong Kong (HK)
- Venue
- Hypertension
- Published
- 2007-01
- Volume
- 49
- Issue
- 1
- Pages
- 69-75
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2122326747
- Cited by
- 1,395
- References
- 35
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 18 · 2023: 29 · 2022: 25 · 2021: 34 · 2020: 35 · 2019: 39 · 2018: 44 · 2017: 53 · 2016: 55 · 2015: 66 · 2014: 77 · 2013: 103 · 2012: 106
- FWCI
- 98.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- hypertension prevalence, hypertension awareness, antihypertensive therapy, blood pressure control, temporal trends, age differences, racial and ethnic differences, non-Hispanic blacks, Mexican Americans, adults
- MeSH terms
- Adult, Aging, Black or African American, Blood Pressure, Female, Goals, Humans, Hypertension, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Nutrition Surveys, United States, Prevalence, Mexican Americans, Black People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review